Health
Penn Study Finds Solid-Tumor Cancer Patients Ineligible for Clinical Trials Receive Immunotherapy at Greater Rates Despite Lack of Benefits – Newswise
Cancer patients who are ineligible for clinical trials receive immune checkpoint inhibitors (ICI) at greater rates than patients…
Newswise — PHILADELPHIA — Cancer patients who are ineligible for clinical trials receive immune checkpoint inhibitors (ICI) at greater rates than patients who are trial eligible despite no survival benefit, according to a new study by researchers at the…
Continue Reading
-
General15 hours ago‘We are here for you’: PM to bring help to flood zones
-
General13 hours agoWe’ve all talked about potential economic consequences for Australia of Trump’s policies. Now they’re happening
-
Noosa News21 hours agoStudents say new facility would be better in rural areas of Queensland
-
General12 hours ago‘I can’t start at zero now’: Aussies call for clarity after super cyber attack